OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-12-31-accounts

REGISTERED COMPANY NUMBER: 04303166 (England and Wales) REGISTERED CHARITY NUMBER: 1090133

REPORT OF THE TRUSTEES AND

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

4 CANCER GROUP

F1 CRT Limited Flat 24 Wellingtonia Court Laine Close Brighton East Sussex BN1 6TD

4 CANCER GROUP

CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

Page
Report of the Trustees 1 to 10
Independent Examiner's Report 11
Statement of Financial Activities 12
Balance Sheet 13
Notes to the Financial Statements 14 to 21
Detailed Statement of Financial Activities 22

4 CANCER GROUP

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

Page 1

4 CANCER GROUP

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

OBJECTIVES AND ACTIVITIES Significant Activities, Objectives And Aims

2023 Key Points

Page 2

About Us

Our Mission

The '4 Cancer Group' exists to help the whole 'family unit' manage the impact of living with cancer.

Why Do We Exist?

Cancer is the toughest fight most of us will ever face. Fifty per cent (50%) of people born in the UK after 1960 will be diagnosed with some form of cancer at some point in their lives. After diagnosis, life is taken over by hospital visits, uncertainty and often financial worries. Adult cancer patients will often need to stop working as a result of their diagnosis and it is also common for a family member to give up work to care for someone who is terminally ill. It is no surprise therefore that the incidence of clinical depression is up to five times higher in patients with cancer than the general population. (Source: European Journal of Cancer).

Importantly, we recognise that cancer has a profound impact on the whole family unit and not just the diagnosed individual; the 4 Cancer Group's focus on the whole family unit sets us apart. As a specialist respite charity, we provide the whole family with relief from the difficulties of living with cancer. We believe in the 'here and now' and strive to help the whole family unit deal with the emotional burden that a cancer diagnosis brings.

Page 2

4 CANCER GROUP

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

What Do We Do?

Primary Objective:

Our experience since 2001 shows that 'time out' with the family provides tangible benefits for both mental and physical health. Over the past 22 years we have developed a diverse and flexible respite portfolio which is designed to fit around complex treatment plans.

From family days out to longer respite breaks in both the UK and abroad, we give families living with cancer something to look forward to at the end of arduous treatment schedules. Our mantra is to 'create memories which last a lifetime'.

Given that a significant number of people we help are terminally ill, the creation of positive memories is of fundamental importance, especially for the family members left behind if the cancer patient later dies. Such trips also help the recently bereaved come to terms with their loss and gives them a positive focus in the months after a loved one has died.

Designed with relaxation in mind, most of our respite activities also give people the opportunity to keep physically active. Keeping active could help to prevent more than 3,000 cases of cancer every year in the UK. (Source: Cancer Research UK).

Secondary Objectives:

(1) To make grants to UK based cancer care institutions. We recognise that good palliative care can make all the difference to both the cancer patient and their wider family. With a focus on 'end of life' care and support, we make grants to hospices and other care institutions to help people in the latter stages of their illness.

(2) Given that we are committed to continuous improvement, research is a key component of our work. We constantly monitor the impact of our respite programmes to ensure that they are delivering maxi-mum benefit. In addition to our own quantitative and qualitative research, we work closely with Loughborough University and the University of Brighton to ensure that we properly understand the needs of the families we help. We are also very interested in the emerging research that both exercise and spending time at altitude can offer a range of health benefits to cancer patients and non-cancer patients alike. Given that elements of our respite programme encourage people to 'get active' and also to spend time in an 'alpine' environment, these are also important areas of focus.

What Do We Deliver?

For the majority of our beneficiary families, their lives have been totally taken over by cancer. As a consequence of all the hospital appointments, complex treatment plans and assessments, families spend much less time with one another. Holidays and short breaks, traditionally the main time of the year when families spend quality time together, are usually the first casualty. And aside from the time constraints, few families can afford to spend time away from home with one another due to the financial impact of a cancer diagnosis.

We continue to develop bespoke respite programmes which accommodate delicate health needs, complex treatment schedules, depleted finances and wider family circumstances. The end result is a respite break tailored to each family where all they need to do is turn up and enjoy some special time with one another. For those families who are truly struggling financially, we add spending vouchers or a dining plan to their break so that they can enjoy their time together without worrying about extra costs.

Who Are Our Beneficiaries?

We continue to broaden the group of people whom we help (our beneficiaries) in terms of cancer type, geographical coverage (UK) and age. Our approach is 100% inclusive in that we provide respite for people of all ages, with any type of cancer, with any disability resulting from cancer (where possible) and at any stage of treatment. For example, the youngest patient we have helped was 20 months and the oldest was 79. We have helped families as far South as Cornwall to Fife in Scotland.

Page 3

4 CANCER GROUP

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

Importantly, we recognise that cancer affects the whole family unit and not just the person who is diagnosed with the disease. Because cancer does not discriminate, neither do we. We help people from any background or socio-demographic group and we rely on our extensive network of medical professionals and partner organisations from across the UK to refer families who are most in need of our help.

Public Benefit, Charitable Cooperation And Fiscal Sponsorship

The activities detailed in this report are a targeted effort to bring families closer together, to help them forget about the cancer that has been dictating their lives and to help them fight on whilst a cure for cancer is found.

We continue to have significant public benefit according to feedback from beneficiary families.

The Trustees confirm they have had due regard to the guidance provided by the Charity Commission in respect of public benefit.

As part of our fiscal sponsorship programme we welcomed two other organisations into the 4 Cancer Group, namely the 'Neil Vines Trust' and 'From Me To You'. ‘From Me To You’ has since become independent thanks to the helping hand we gave them in their early years.

We also continue to work collaboratively alongside other charitable organisations such as NHS Trusts, Macmillan, Youth Cancer Trust, Something To Look Forward To and The Teenage Cancer Trust in the delivery of quality respite.

Page 4

4 CANCER GROUP

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

ACHIEVEMENT AND PERFORMANCE Charitable Activities 2023 Impact

Despite the huge reduction in income since 2020 (down over 90% from pre-pandemic levels), we managed to deliver / facilitate 2,470 respite days in 2023. This represents the sixth highest annual output since 2001.

In 2023, we achieved 6.77 years of respite days. This meant that every day of the year we had nearly 7 people away on holiday.

We helped 415 people in 2023, the eight highest number in our 22 year history. Since the charity started in 2001 we have helped 7,214 people and delivered a total of 34,099 respite days.

Due to the pandemic and the recent cost of living crisis, requests for support have never been higher. To meet this increased demand, we spent nearly three times our 2023 annual income on respite activity in 2023, operating at a deficit of £75,590. This was made possible by delving deeply into our reserves as in the previous year (2022).

2023 Respite Partners

Due to the increased cost of holidays after Brexit and the COVID-19 pandemic, our 2023 operations were limited to:

We continue to be very grateful to a number of organisations who provide a very sympathetic service to our beneficiaries. These include Haven, Hoseasons, Wightlink, Village Club du Soleil and Blair's Holiday Parks.

Family Feedback In 2023

We measure a number of factors to understand our impact. Both quantitative and qualitative feedback is collected in addition to evaluating the wellbeing of our beneficiaries post-delivery. Of key significance are our research partnerships with Loughborough University with the University of Brighton who have helped us to continuously improve what we do.

Each respite day we deliver is designed to give families a break from the trauma of living with cancer. Whether on a boat, in the middle of a forest, up a mountain or down by the sea, our respite days are full of fresh air, fun and togetherness.

Each break is specifically designed to create lasting memories. We aim to recharge batteries, to re-strengthen bonds and to give families the energy to carry on the daily battle that is 'living with cancer'.

Below is a testimonial from just one of the families we helped in 2023. The difference we continue to make to peoples' lives is clear:

“Just a note to say thank you so much for the holiday. We had an absolutely fantastic time so much so that my daughter didn't want to leave. The site, accommodation and staff were lovely and we've given our daughter Isabella some amazing memories which we know she will cherish.

I'm 42 years old. I've worked all my life as an electrical engineer and never had any health problems. Unfortunately I was diagnosed with kidney cancer last year and the treatment was unsuccessful. I'm now terminal (2-3 months). I had to give up work due to my health problems a few months ago and because I have assets (own my own home) I'm only entitled to limited benefits that don't even cover our living costs.

We would not have been able to afford to go on holiday again. This really was an amazing gift and we cannot thank you enough for what this means to me and my partner Lucy by having this time with Isabella and making these memories”.

Thank you again. David

Page 5

4 CANCER GROUP

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

Targets

The charity has a series of medium and long-term targets.

A Century Of Respite

At the end of 2016, the charity had provided 17,951 respite days to 4,062 people (since starting in 2001). This represented the equivalent of just under 50 years (half a century) of respite days when viewed as a whole. Consequently, the Trustees decided in late 2016 to set a target to reach 100 years (a century) of respite days and to help a further 4,000 people.

Based on an average of the charity's output for the previous three years, we set an ambitious minimum target to provide 2,000 respite days to circa 400 people every year. By setting a baseline service level we set a target of the end of 2025 to achieve the 100 year target. Given the first 50 years took us nearly 16 years to achieve, the target would require us to deliver the same number of respite days in roughly half that time-frame (8 years).

Due to COVID-19 restrictions, we were only able to deliver 643 respite days (combined) for 2020 and 2021. To be on schedule to meet our '100 years of respite' target by the end of 2025, we needed to have delivered 32,500 respite days by the end of 2023.

Despite the huge reduction in income since the pandemic (over 90% since 2019), we delivered 2,470 respite days in 2023. We were 1,599 respite days ahead of schedule at the end of 2023. This was only made possible by massively overachieving on our annual targets between 2016 and 2019.

Cumulative Cumulative Years
Respite Days Respite Days of Respite
Year Number of People Provided Provided Delivered
2001 0 0 0 0.00
2002 2 2 2 0.01
2003 35 36 38 0.10
2004 57 91 129 0.35
2005 243 798 927 2.54
2006 195 891 1,818 4.98
2007 180 1,004 2,822 7.73
2008 246 755 3,577 9.80
2009 255 1,060 4,637 12.70
2010 305 1,648 6,285 17.22
2011 330 1,404 7,689 21.07
2012 390 1,764 9,453 25.90
2013 340 1,421 10,874 29.79
2014 468 2,078 12,952 35.48
2015 539 2,286 15,238 41.75
2016 477 2,713 17,951 49.18
2017 635 2,813 20,764 56.89
2018 853 3,914 24,678 67.61
2019 545 2,482 27,160 74.41
2020 13 60 27,220 75.58
2021 150 583 27,803 76.17
2022 541 3,826 31,629 86.65
2023 415 2,470 34,099 93.42
End of 2025 Target 8,000 36,500 36,500 100 Years

Page 7

4 CANCER GROUP

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

Holiday Property Acquisition

In 2017, we announced an intention to purchase land or buildings so that we could start to supply respite breaks directly to beneficiary families, thereby removing our reliance on third party providers. This was in direct response to the charity's growing inability to source holidays at discounted rates, especially during school holiday periods.

Brexit, the COVID-19 pandemic and the cost of living crisis have further accentuated the problem. The cost of holidays has increased markedly as travel companies have tried to recoup some of their losses from 2020 and 2021. Consequently, our ability to buy in holidays at attractive rates has been severely impinged.

By owning our own respite facilities, we will be able to fix a large percentage of our costs whilst also providing availability throughout the year at a constant rate. We can also ensure that cleaning standards are kept at the highest level to protect vulnerable families where a family member is immunocompromised. Shared holiday facilities at holiday parks still make many of our families nervous.

One 2 bedroom house has the potential to provide a holiday for at least 160 people every year at 77% occupancy (40 weeks out of 52). Consequently, a two bedroom property has the potential to provide at least 1,120 respite days every year. Purchase and administration costs aside, the cost per respite day could be nearly halved by owning our own respite facilities even at 77% utilization.

We agreed the purchase of our first respite holiday property on the Isle of Wight in 2023. The purchase price was agreed in February 2023 but completion had still not occurred by the end of December. At the time of writing this report (August 2024), the house has been operational for five months and the feedback from families has been simply fantastic.

Without the generous help from grant making trusts and foundations, we simply would not have had the funds to buy this incredible property. Moreover, this generosity has given us the chance to vindicate the charity's decision to operate its own respite properties. Not only can we offer a much improved respite 'product' but also one that costs the charity much less (we forecast up to 50% less going forward).

Our longer term objective is to add holiday properties in other parts of the United Kingdom to serve local people who are in urgent need of help. Ideally we would add to our holiday portfolio over the coming five years with properties near the Brecon Beacons, the Lake District, Norfolk and the West Coast of Scotland. This will give us excellent geographic coverage across the wider UK region. We are developing a Respite Property Fund which will enable us to expand our property portfolio across the UK.

10,000 People / 1,000 People Every Year

If we can hit our '100 Years Of Respite' target (hopefully by the close of 2025), we forecast that we will have helped in the region of 8,000 people. The next logical target thereafter is to reach the obvious mile-stone of helping 10,000 people in total. By the end of 2023, we had helped 7,214 people.

Every day, nearly 1,000 people in the United Kingdom are told they have some form of cancer (Source: Cancer Research UK). Our longer term objective is therefore to provide respite services for 1,000 people every year.

Four respite properties (with a mix of two or three-bedrooms) has the potential to help 1,000 people every year with a respite day total of 6,000 days. However, given the current availability of funds, we are fully aware that this is a very ambitious target.

FINANCIAL REVIEW

Financial Position

Total incoming resources for the year were £34,578 (£56,945 in 2022) and resources expended £110,168 (£153,588 in 2022).

There was a retained deficit for the year on unrestricted activities of £75,590 (2022 deficit £80,832) and this has been deducted from the reserves brought forward of £214,300 to leave £138,710 which will be carried forward.

There was no movement on restricted reserves and this remain unchanged at £15,957.

Page 7

4 CANCER GROUP

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

FINANCIAL REVIEW

Reserves Policy

The majority of the families who are referred to us by NHS trusts, GPs and other care institutions have complex medical needs. Due to shifting medical treatment schedules it is quite common for us to book and re-book a respite holiday several times.

Consequently, a large proportion of the families we help will stay on our waiting list for 18 months. To honour the promises we make, our reserves policy is designed to serve an 18 month waiting list at previous year levels.

Although we 'fast track' families where there is a terminal diagnosis, many patients die before they are able to take a respite holiday with their family. The focus then shifts to a bereavement situation where we provide a private space for the family to grieve.

Due to the ongoing effects of the COVID-19 pandemic and the more recent cost of living crisis, requests for support have never been higher. Demand for our services greatly outweighs supply however.

We delivered 2,470 respite days in 2023. An 18 month reserve policy would require us to retain enough funds to deliver 3,705 respite days (2,470 days x 1.5 years = 3,705). This would require unrestricted re-serves of £165,243 if each respite day in 2024 costs the same as it did in 2023.

However, with the consumer price index (CPI) of domestic holiday centres in the United Kingdom reporting a 17.8% increase in holiday prices over the course of 2023, we forecast the real cost in 2024 could be much higher at circa £200,000. (Source: Consumer Price Index of holiday centers, Statista UK)

Put simply, we no longer hold enough in reserves to serve an 18 month waiting list.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing Document

The organisation is a charitable company limited by guarantee, incorporated on 11 October 2001 (Company Number 4303166) and registered as a Charity on 17 January 202 (Charity Number 1090133).

The Charity initiated its operations on 25 April 2001.

The Company was established under a Memorandum of Association which established the objects and powers of the charitable company and is governed under its Articles of Association. Under those Articles, the members of the Board of Directors/Trustees are re-elected at each AGM.

Page 8

4 CANCER GROUP

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

STRUCTURE, GOVERNANCE AND MANAGEMENT Charity Structure

The '4 Cancer Group' is made up of five fundraising divisions: Sail 4 Cancer, Ski 4 Cancer, Run 4 Cancer, Bike 4 Cancer and The Neil Vines Trust. Family respite services are delivered at 'group' level via the '4 Cancer' brand (please visit www.4cancer.org for more information). We continue to refine our structure so that we can support more families affected by cancer every year.

To reduce costs and make us more efficient, we started an ambitious cost cutting programme in 2019 which continued into 2023. Over the same period we have moved offices twice, reducing office expenditure considerably. This has resulted in a 65% reduction in administration costs.

Since 2019 the charity has drastically changed its staffing model, moving from a salaried team of seven people in 2019 to zero employees since. Our current management approach is to employ the services of experts where needed on reduced commercial rates.

We started 2023 with three trustees and finished the year with four. The current trustee team consists of two marketing consultants, a shipping materials supplier and a fire training specialist. We intend to grow the trustee team in 2024.

We also have a number of volunteer patrons and ambassadors. These include Sir Ben Ainslie OBE, Andrew Pindar OBE DL, Dee Caffari MBE, Franz Klammer, Graham Bell and Eddie 'The Eagle' Edwards. We would also like to pay tribute to Baron Michael Boyce, Admiral Of The Fleet, the Lord Boyce KG GCB OBE KStJ DL who served as a Patron for over twenty years (from 2001 until his death in November 2022).

People

Our management approach is to employ a small and efficient team and to bring in experts on a contracted and temporary basis where needed e.g. marketing, event management, IT etc. In 2023, the charity employed four people on a part-time basis, one of whom is a trustee.

Risk Management

The Trustee board reviewed a number of principal risks and uncertainties during 2023. The Board has strategies and controls in place to mitigate the operational risks highlighted below:

When working towards this target we continue to ensure that we:

REFERENCE AND ADMINISTRATIVE DETAILS

Registered Company number

04303166 (England and Wales)

Registered Charity number

1090133

Page 9

4 CANCER GROUP

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2023

Registered office

35 Lavant Street Petersfield GU32 3EL

Trustees

A J Hayward A J B Nicholson D J Gill (appointed 1.1.23) S J Bowker (appointed 1.9.23)

Company Secretary

A J Hayward

Independent Examiner

Christopher Robert Tyler FCA DChA FCIE F1 CRT Limited Flat 24 Wellingtonia Court Laine Close Brighton East Sussex BN1 6TD

EVENTS SINCE THE END OF THE YEAR

Information relating to events since the end of the year is given in the notes to the financial statements.

STATEMENT OF TRUSTEES' RESPONSIBILITIES

The trustees (who are also the directors of 4 Cancer Group for the purposes of company law) are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing those financial statements, the trustees are required to:

The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the board of trustees on 14 October 2024 and signed on its behalf by:

A.J.Hayward

A J Hayward - Trustee

Page 10

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF 4 CANCER GROUP

Independent examiner's report to the trustees of 4 Cancer Group ('the Company')

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2023.

Responsibilities and basis of report

As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Christopher Robert Tyler FCA DChA FCIE

F1 CRT Limited Flat 24 Wellingtonia Court Laine Close Brighton East Sussex BN1 6TD

14 October 2024

Page 11

4 CANCER GROUP

STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2023

Unrestricted
funds
Notes
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
2
30,926
Charitable activities
4
Respite Holidays for Beneficiaries
-
Investment income
3
3,652
Total
34,578
EXPENDITURE ON
Raising funds
5
32,475
Charitable activities
6
Respite Holidays for Beneficiaries
68,423
Support costs
9,270
Total
110,168
NET INCOME/(EXPENDITURE)
(75,590)
RECONCILIATION OF FUNDS
Total funds brought forward
214,300
TOTAL FUNDS CARRIED FORWARD
138,710		 Restricted
funds
£
-
-
-
-
-
-
-
-
-
15,957
15,957		 2023
Total
funds
£
30,926
-
3,652
34,578
32,475
68,423
9,270
110,168
(75,590)
230,257
154,667		 2022
Total
funds
£
55,553
625
767
56,945
31,929
112,539
9,120
153,588
(96,643)
326,900
230,257

The notes form part of these financial statements

Page 12

4 CANCER GROUP

BALANCE SHEET 31 DECEMBER 2023

Unrestricted
funds
Notes
£
CURRENT ASSETS
Debtors
14
8,869
Cash at bank
208,265
217,134
CREDITORS
Amounts falling due within one year
15
(78,424)
NET CURRENT ASSETS
138,710
TOTAL ASSETS LESS CURRENT
LIABILITIES
138,710
NET ASSETS
138,710
FUNDS
16
Unrestricted funds
Restricted funds
TOTAL FUNDS		 Restricted
funds
£
-
15,957
15,957
-
15,957
15,957
15,957		 2023
Total
funds
£
8,869
224,222
233,091
(78,424)
154,667
154,667
154,667
138,710
15,957
154,667		 2022
Total
funds
£
7,436
270,288
277,724
(47,467)
230,257
230,257
230,257
214,300
15,957
230,257

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.

The financial statements were approved by the Board of Trustees and authorised for issue on 14 October 2024 and were signed on its behalf by:

A.J.Hayward

A J Hayward - Trustee

The notes form part of these financial statements

Page 13

4 CANCER GROUP

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charitable company, which is a public benefit entity under FRS102, have been prepared in accordance with the Charities SORP (FRS102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2015)', Financial Reporting Standard FRS102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The accounts are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The trustees/directors consider that there are no material uncertainties about the company's ability to continue as a going concern.

Income

All income is recognised in the Statement of Financial Activities (SOFA) once the charity has legal entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Income from donations is accounted for as received by the charity. The income from fundraising ventures is shown gross, with the associated costs included in fundraising costs. The value of voluntary work is not included in the financial statements.

Grants are recognised in full in the SOFA in the year in which they are receivable. Grants for the purchase of fixed assets are credited to restricted income when they are receivable. Where the use of the asset is restricted, depreciation is charged against the restricted fund. Where the use of the asset is not restricted it is transferred to the general fund.

Other income, including investment income and commissions, is recorded on an accruals basis.

For legacies, entitlement is taken on a case by case basis as the earlier on the date on which: the charity is aware that probate has been granted, the estate has been finalised and notification has been made by the executor(s) to the charity that a distribution will be made, or when a distribution is received from the estate. Receipt of a legacy, in whole or in part, is only considered probable when the amount can be measured reliably and the charity has been notified of the executor's intention to make a distribution. If the legacy is in the form of an asset other than cash or an asset listed on a recognised stock exchange, recognition is subject to the value of the asset being able to be reliably measured and title to the asset has passed to the charity. Where legacies have been notified to the charity or the charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy is treated as a contingent asset and disclosed if material.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure, including irrecoverable VAT, is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Raising funds

Costs of generating voluntary income includes relevant fundraising and publicity costs.

Charitable activities

Costs of charitable activities comprise direct expenditure. Where costs cannot be directly attributed to particular headings, they have been allocated to activities on a basis consistent with the use of resources.

Support cots

Support costs include those costs, such as independent examiners' fees, associated with constitutional and statutory requirements.

continued...

Page 14

4 CANCER GROUP

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2023

1. ACCOUNTING POLICIES - continued

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life :

Fixtures and fittings - 20% on cost Computer equipment - 50% on cost

Assets costing less than £500 are written off to the Statement of Financial Activities.

Taxation

The Charity is considered to pass the tests set out in Paragraph 1 Schedule 6 Finance Act 2010 and therefore it meets the definition of a charitable company for UK Corporation Tax purposes. Accordingly the Charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the . trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements

2. DONATIONS AND LEGACIES

Donations
3.
INVESTMENT INCOME
Deposit account interest
4.
INCOME FROM CHARITABLE ACTIVITIES
Activity
Other income - insurance
monies
Respite Holidays for Beneficiaries		 2023
£
30,926
2023
£
3,652
2023
£
-		 2022
£
55,553
2022
£
767
2022
£
625

Page 15

continued...

4 CANCER GROUP

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2023

5. RAISING FUNDS

Raising donations and legacies

Raising donations and legacies
Costs of generating funds
Fundraising, PR and marketing
6.
CHARITABLE ACTIVITIES COSTS		 2023
£
16,425
16,050
32,475		 2022
£
15,879
16,050
31,929
Direct
Support
Costs (see
costs (see
note 7)
note 8)
£
£
Respite Holidays for Beneficiaries
68,423
-
Support costs
-
9,270
68,423
9,270
7.
DIRECT COSTS OF CHARITABLE ACTIVITIES
2023
£
Holiday booking and administration
28,050
Respite holidays for beneficiaries
31,259
Premises costs
4,577
Postage and stationery
159
Travel and subsistence
129
Insurance
322
Computer costs
2,529
General expenses
85
Bank charges
713
Accountancy and Taxation
600
Depreciation
-
68,423
8.
SUPPORT COSTS
Governance
Management
costs
£
£
Support costs
8,100
1,170

Page 16

continued...

4 CANCER GROUP

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2023

8. SUPPORT COSTS - continued

Support costs, included in the above, are as follows:

Support costs, included in the above, are as follows:
2023 2022
Support Total
costs activities
£ £
Financial management 8,100 8,100
Independent examination 1,170 1,020
9,270 9,120
NET INCOME/(EXPENDITURE)
Net income/(expenditure) is stated after charging/(crediting):
2023 2022
£ £
Depreciation - owned assets - 310
Independent Examination 1,170 1,020

9. NET INCOME/(EXPENDITURE)

Net income/(expenditure) is stated after charging/(crediting):

10. TRUSTEES' REMUNERATION AND BENEFITS

One Trustee, Andrew Hayward, received remuneration of £24,000 (2022: £24,000) in connection with his role as fundraising and marketing consultant.

Trustees' expenses

There were no trustees' expenses paid for the year ended 31 December 2023 nor for the year ended 31 December 2022.

11. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES

Unrestricted
funds
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
52,803
Charitable activities
Respite Holidays for Beneficiaries
625
Investment income
767
Total
54,195
EXPENDITURE ON
Raising funds
31,929
Charitable activities
Respite Holidays for Beneficiaries
93,978
Support costs
9,120
Total
135,027
NET INCOME/(EXPENDITURE)
(80,832)		 Restricted
funds
£
2,750
-
-
2,750
-
18,561
-
18,561
(15,811)		 Total
funds
£
55,553
625
767
56,945
31,929
112,539
9,120
153,588
(96,643)

continued...

Page 17

4 CANCER GROUP

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2023

11. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted Restricted Total
funds funds funds
£ £ £
RECONCILIATION OF FUNDS
Total funds brought forward 295,132 31,768 326,900
TOTAL FUNDS CARRIED FORWARD 214,300 15,957 230,257
12. INTANGIBLE FIXED ASSETS
Computer
software
£
COST
At 1 January 2023 1,021
Disposals (1,021)
At 31 December 2023 -
AMORTISATION
At 1 January 2023 1,021
Eliminated on disposal (1,021)
At 31 December 2023 -
NET BOOK VALUE
At 31 December 2023 -
At 31 December 2022 -
13. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£ £ £
COST
At 1 January 2023 1,892 8,791 10,683
Disposals (1,892) (8,791) (10,683)
At 31 December 2023 - - -
DEPRECIATION
At 1 January 2023 1,892 8,791 10,683
Eliminated on disposal (1,892) (8,791) (10,683)
At 31 December 2023 - - -
NET BOOK VALUE
At 31 December 2023 - - -
At 31 December 2022 - - -

continued...

Page 18

4 CANCER GROUP

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2023

14. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Prepayments and accrued income
15.
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Trade creditors
Social security and other taxes
Accrued expenses
Funding in advance		 2023
£
8,869
2023
£
5,016
468
1,740
71,200
78,424		 2022
£
7,436
2022
£
9,169
468
4,630
33,200
47,467
The funding in advance relates to monies received to purchase a holiday home (see Note 18).
16.
MOVEMENT IN FUNDS
Net
movement
At 1.1.23
in funds
£
£
Unrestricted funds
General fund
21,715
(75,590)
Respite - providing respite to families
affected by cancer who are already talking
to but are not ready to travel yet.
100,000
-
Respite - monies set aside for website
development to provide a better respite
process and improve our digital
fundraising capabilities.
12,585
-
Building - monies set aside to purchase
land/buildings to offer a baseline of respite
places directly through our own respite
facility.
80,000
-
214,300
(75,590)
Restricted funds
Young Carers
2,000
-
Families living in Nottinghamshire.
1,265
-
Families living in Oxfordshire.
5,921
-
Families living in Worcester.
1,440
-
Families living in Hull and East Yorkshire
2,737
-
Families living in Berkshire
2,594
-
15,957
-
TOTAL FUNDS
230,257
(75,590)		 At
31.12.23
£
(53,875)
100,000
12,585
80,000
138,710
2,000
1,265
5,921
1,440
2,737
2,594
15,957
154,667

continued...

Page 19

4 CANCER GROUP

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2023

16. MOVEMENT IN FUNDS - continued

Net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
TOTAL FUNDS
Comparatives for movement in funds
Unrestricted funds
General fund
Respite - providing respite to families
affected by cancer who are already talking
to but are not ready to travel yet.
Respite - monies set aside for website
development to provide a better respite
process and improve our digital
fundraising capabilities.
Building - monies set aside to purchase
land/buildings to offer a baseline of respite
places directly through our own respite
facility.
Restricted funds
Young Carers
Families living in Devon.
Families living in Nottinghamshire.
Families living in Oxfordshire.
Families living in Worcester.
Families living in Leicestershire.
Families living in the South of England
Families living in Hull and East Yorkshire
Families living in Berkshire
Families living in Kent
TOTAL FUNDS		 Incoming
resources
£
34,578
34,578
At 1.1.22
£
102,547
100,000
12,585
80,000
295,132
2,000
300
2,100
3,921
2,457
450
12,500
5,000
3,000
40
31,768
326,900		 Resources
Movement
expended
in funds
£
£
(110,168)
(75,590)
(110,168)
(75,590)
Net
movement
At
in funds
31.12.22
£
£
(80,832)
21,715
-
100,000
-
12,585
-
80,000
(80,832)
214,300
-
2,000
(300)
-
(835)
1,265
2,000
5,921
(1,017)
1,440
(450)
-
(12,500)
-
(2,263)
2,737
(406)
2,594
(40)
-
(15,811)
15,957
(96,643)
230,257

continued...

Page 20

4 CANCER GROUP

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2023

16. MOVEMENT IN FUNDS - continued

Comparative net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Restricted funds
Families living in Devon.
Families living in Nottinghamshire.
Families living in Oxfordshire.
Families living in Worcester.
Families living in Leicestershire.
Families living in the South of England
Families living in Hull and East Yorkshire
Families living in Berkshire
Families living in Kent
TOTAL FUNDS		 Incoming
resources
£
54,195
-
750
2,000
-
-
-
-
-
-
2,750
56,945		 Resources
Movement
expended
in funds
£
£
(135,027)
(80,832)
(300)
(300)
(1,585)
(835)
-
2,000
(1,017)
(1,017)
(450)
(450)
(12,500)
(12,500)
(2,263)
(2,263)
(406)
(406)
(40)
(40)
(18,561)
(15,811)
(153,588)
(96,643)

17. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 December 2023.

18. POST BALANCE SHEET EVENTS

On the 17 January 2024 the charity purchased a holiday home in Yarmouth, Isle of Wight for £68,000 plus costs.

The property purchase was funded by donations.

19. STATUTORY INFORMATION

4 Cancer Group is a Charitable Company, limited by guarantee, registered in England and Wales and has no share capital. No one member has overall control of the Charity.

The Company's registered number and registered office address can be found in the Legal and Administrative Information section of the accounts.

Page 21

4 CANCER GROUP

DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2023

INCOME AND ENDOWMENTS
Donations and legacies
Donations
Investment income
Deposit account interest
Charitable activities
Other income - insurance monies
Total incoming resources
EXPENDITURE
Raising donations and legacies
Costs of generating funds
Fundraising, PR and marketing
Charitable activities
Holiday booking and administration
Respite holidays for beneficiaries
Premises costs
Postage and stationery
Travel and subsistence
Insurance
Computer costs
General expenses
Bank charges
Accountancy and Taxation
Fixtures and fittings
Support costs
Management
Financial management
Governance costs
Independent examination
Total resources expended
Net expenditure		 2023
£
30,926
3,652
-
34,578
16,425
16,050
32,475
28,050
31,259
4,577
159
129
322
2,529
85
713
600
-
68,423
8,100
1,170
110,168
(75,590)		 2022
£
55,553
767
625
56,945
15,879
16,050
31,929
28,050
73,548
2,162
957
83
1,100
4,602
342
785
600
310
112,539
8,100
1,020
153,588
(96,643)

This page does not form part of the statutory financial statements

Page 22